These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12898349)

  • 1. Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer's disease.
    Mulder C; Wahlund LO; Teerlink T; Blomberg M; Veerhuis R; van Kamp GJ; Scheltens P; Scheffer PG
    J Neural Transm (Vienna); 2003 Aug; 110(8):949-55. PubMed ID: 12898349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry.
    Grimm MO; Grösgen S; Riemenschneider M; Tanila H; Grimm HS; Hartmann T
    J Chromatogr A; 2011 Oct; 1218(42):7713-22. PubMed ID: 21872257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
    Bittner DM; Heinze HJ; Kaufmann J
    J Alzheimers Dis; 2013; 36(1):155-63. PubMed ID: 23579327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DHA-PC and PSD-95 decrease after loss of synaptophysin and before neuronal loss in patients with Alzheimer's disease.
    Yuki D; Sugiura Y; Zaima N; Akatsu H; Takei S; Yao I; Maesako M; Kinoshita A; Yamamoto T; Kon R; Sugiyama K; Setou M
    Sci Rep; 2014 Nov; 4():7130. PubMed ID: 25410733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The load of amyloid-β oligomers is decreased in the cerebrospinal fluid of Alzheimer's disease patients.
    Sancesario GM; Cencioni MT; Esposito Z; Borsellino G; Nuccetelli M; Martorana A; Battistini L; Sorge R; Spalletta G; Ferrazzoli D; Bernardi G; Bernardini S; Sancesario G
    J Alzheimers Dis; 2012; 31(4):865-78. PubMed ID: 22717612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific, rapid, and sensitive enzymatic measurement of sphingomyelin, phosphatidylcholine and lysophosphatidylcholine in serum and lipid extracts.
    Hidaka H; Yamauchi K; Ohta H; Akamatsu T; Honda T; Katsuyama T
    Clin Biochem; 2008 Oct; 41(14-15):1211-7. PubMed ID: 18619432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease.
    Abe T; Tohgi H; Isobe C; Murata T; Sato C
    J Neurosci Res; 2002 Nov; 70(3):447-50. PubMed ID: 12391605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer's disease and vascular dementia.
    Jia JP; Jia JM; Zhou WD; Xu M; Chu CB; Yan X; Sun YX
    Chin Med J (Engl); 2004 Aug; 117(8):1161-4. PubMed ID: 15361288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced CSF PLTP activity in Alzheimer's disease and other neurologic diseases; PLTP induces ApoE secretion in primary human astrocytes in vitro.
    Vuletic S; Peskind ER; Marcovina SM; Quinn JF; Cheung MC; Kennedy H; Kaye JA; Jin LW; Albers JJ
    J Neurosci Res; 2005 May; 80(3):406-13. PubMed ID: 15795933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stability of polyunsaturated fatty acid in phosphatidylcholine liposomes.
    Araseki M; Yamamoto K; Miyashita K
    Biosci Biotechnol Biochem; 2002 Dec; 66(12):2573-7. PubMed ID: 12596850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
    Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
    Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of selenium, redox status and their association with plasma amyloid/tau in Alzheimer's disease.
    Krishnan S; Rani P
    Biol Trace Elem Res; 2014 May; 158(2):158-65. PubMed ID: 24682919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF amyloid-β peptides in neuropathologically diagnosed dementia with Lewy bodies and Alzheimer's disease.
    Mollenhauer B; Esselmann H; Trenkwalder C; Schulz-Schaeffer W; Kretzschmar H; Otto M; Wiltfang J; Bibl M
    J Alzheimers Dis; 2011; 24(2):383-91. PubMed ID: 21297274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano-HPLC-MS analysis of phospholipids in cerebrospinal fluid of Alzheimer's disease patients--a pilot study.
    Kosicek M; Kirsch S; Bene R; Trkanjec Z; Titlic M; Bindila L; Peter-Katalinic J; Hecimovic S
    Anal Bioanal Chem; 2010 Dec; 398(7-8):2929-37. PubMed ID: 20953867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid Aβ1-40 improves differential dementia diagnosis in patients with intermediate P-tau181P levels.
    Slaets S; Le Bastard N; Martin JJ; Sleegers K; Van Broeckhoven C; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2013; 36(4):759-67. PubMed ID: 23666174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidylcholine as a precursor of choline for acetylcholine synthesis.
    Blusztajn JK; Liscovitch M; Mauron C; Richardson UI; Wurtman RJ
    J Neural Transm Suppl; 1987; 24():247-59. PubMed ID: 3316498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2'-deoxyguanosine in the CSF of patients with Alzheimer's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process.
    Isobe C; Abe T; Terayama Y
    J Neurol; 2010 Mar; 257(3):399-404. PubMed ID: 19784856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
    Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
    Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysophosphatidic acid, alkylglycerophosphate and alkylacetylglycerophosphate increase the neuronal nuclear acetylation of 1-acyl lysophosphatidyl choline by inhibition of lysophospholipase.
    Baker RR; Chang HY
    Mol Cell Biochem; 1999 Aug; 198(1-2):47-55. PubMed ID: 10497877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arachidonic acid-containing phosphatidylcholine species are increased in selected brain regions of a depressive animal model: implications for pathophysiology.
    Green P; Anyakoha N; Yadid G; Gispan-Herman I; Nicolaou A
    Prostaglandins Leukot Essent Fatty Acids; 2009 Apr; 80(4):213-20. PubMed ID: 19342208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.